{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:05:10Z","timestamp":1790697910560,"version":"4.1.0"},"reference-count":127,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1696,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1365-2796.2010.02334.x","type":"journal-article","created":{"date-parts":[[2010,12,10]],"date-time":"2010-12-10T13:04:44Z","timestamp":1291986284000},"page":"243-257","source":"Crossref","is-referenced-by-count":66,"title":["Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?"],"prefix":"10.1111","volume":"269","author":[{"given":"I.","family":"Loell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,9]]},"reference":[{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"Engel","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","article-title":"Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies","volume":"29","author":"Hohlfeld","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1164\/rccm.2202005","article-title":"Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments","volume":"166","author":"Reid","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1096\/fj.09-144782","article-title":"Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies","volume":"24","author":"Grundtman","year":"2010","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","article-title":"Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis","volume":"58","author":"Grundtman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","article-title":"Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction","volume":"52","author":"Nagaraju","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells","volume":"183","author":"Fasth","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cytogfr.2007.04.002","article-title":"How TNF was recognized as a key mechanism of disease","volume":"18","author":"Clark","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002281-200111000-00005","article-title":"Effect of tumor necrosis factor-alpha on skeletal muscle metabolism","volume":"13","author":"Li","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.dci.2003.09.008","article-title":"Tumor necrosis factors","volume":"28","author":"Goetz","year":"2004","journal-title":"Dev Comp Immunol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/002215540104900807","article-title":"The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha(\u2212\/\u2212) and TNF-alpha(\u2212\/\u2212)\/LT-alpha(\u2212\/\u2212) mice","volume":"49","author":"Collins","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"C370","DOI":"10.1152\/ajpcell.00453.2002","article-title":"TNF-alpha is a mitogen in skeletal muscle","volume":"285","author":"Li","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005072-199603000-00009","article-title":"Cytokine expression profile in idiopathic inflammatory myopathies","volume":"55","author":"Tews","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1096\/fj.02-0187fje","article-title":"Physiological role of tumor necrosis factor alpha in traumatic muscle injury","volume":"16","author":"Warren","year":"2002","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08916930600622256","article-title":"Cytokines in idiopathic inflammatory myopathies","volume":"39","author":"Salomonsson","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.22388","article-title":"Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies","volume":"56","author":"Grundtman","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"10.1111\/j.1365-2796.2010.02334.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","article-title":"The paradigm of IL-6: from basic science to medicine","volume":"4","author":"Naka","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","article-title":"Clinical value of blocking IL-6 receptor","volume":"21","author":"Mima","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood.V75.1.40.40","article-title":"Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF","volume":"75","author":"Schindler","year":"1990","journal-title":"Blood"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1152\/ajpendo.00074.2003","article-title":"IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans","volume":"285","author":"Steensberg","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI118398","article-title":"Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice","volume":"97","author":"Tsujinaka","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-induced skeletal muscle atrophy","volume":"98","author":"Haddad","year":"2005","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/japplphysiol.00080.2007","article-title":"Role of myokines in exercise and metabolism","volume":"103","author":"Pedersen","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1096\/fj.04-3278fje","article-title":"Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6","volume":"19","author":"Keller","year":"2005","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","article-title":"Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy","volume":"7","author":"Serrano","year":"2008","journal-title":"Cell Metab"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1748-1716.2009.02029.x","article-title":"Overload-induced skeletal muscle extracellular matrix remodelling and myofibre growth in mice lacking IL-6","volume":"197","author":"White","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.2010.1","article-title":"Is interleukin-6 receptor blockade the Holy Grail for inflammatory diseases?","volume":"87","author":"Febbraio","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s000110050331","article-title":"Interleukin-15 and its role in chronic inflammatory diseases","volume":"47","author":"Kirman","year":"1998","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/intimm\/dxf062","article-title":"Increased IL-15 production of muscle cells in polymyositis and dermatomyositis","volume":"14","author":"Sugiura","year":"2002","journal-title":"Int Immunol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1065-6995(03)00172-0","article-title":"Interleukin-15 increases myosin accretion in human skeletal myogenic cultures","volume":"27","author":"Furmanczyk","year":"2003","journal-title":"Cell Biol Int"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB41|cit41","first-page":"471","article-title":"Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect","volume":"16","author":"Busquets","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats","volume":"83","author":"Carbo","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1113\/jphysiol.2007.139618","article-title":"Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition","volume":"584","author":"Nielsen","year":"2007","journal-title":"J Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/bbrc.1997.6435","article-title":"Interleukin-15 promotes angiogenesis in vivo","volume":"233","author":"Angiolillo","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","article-title":"The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway","volume":"3","author":"Gardella","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.20220","article-title":"Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids","volume":"50","author":"Ulfgren","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/ATVBAHA.107.153429","article-title":"Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration","volume":"27","author":"De Mori","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1128\/MCB.24.11.4880-4894.2004","article-title":"Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding","volume":"24","author":"Sorci","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1074\/jbc.M509436200","article-title":"The amphoterin (HMGB1)\/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo","volume":"281","author":"Riuzzi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI200113416","article-title":"Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes","volume":"108","author":"Tilley","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1748-1716.1979.tb06424.x","article-title":"Conversion of arachidonic acid to prostaglandins in homogenates of human skeletal muscle and kidney","volume":"106","author":"Berlin","year":"1979","journal-title":"Acta Physiol Scand"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB52|cit52","first-page":"1243","article-title":"Muscle injuries and repair: the role of prostaglandins and inflammation","volume":"18","author":"Prisk","year":"2003","journal-title":"Histol Histopathol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0021-9258(19)68084-1","article-title":"Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle","volume":"257","author":"Rodemann","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-4827(87)90386-7","article-title":"The role of hormones and prostanoids in the in vitro proliferation and differentiation of human myoblasts","volume":"172","author":"Zalin","year":"1987","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yexcr.2005.08.009","article-title":"Stretch-induced myoblast proliferation is dependent on the COX2 pathway","volume":"310","author":"Otis","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/000163501317153185","article-title":"Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle","volume":"59","author":"Hedenberg-Magnusson","year":"2001","journal-title":"Acta Odontol Scand"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/PL00000320","article-title":"Release of algesic substances in human experimental muscle pain","volume":"51","author":"Tegeder","year":"2002","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB58|cit58","first-page":"940","article-title":"Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis","volume":"27","author":"Nyberg","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198303103081002","article-title":"Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever","volume":"308","author":"Baracos","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0304-3959(03)00115-5","article-title":"Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats","volume":"104","author":"Schafers","year":"2003","journal-title":"Pain"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1096\/fj.06-7070com","article-title":"Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion","volume":"21","author":"Bondesen","year":"2007","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10974-008-9154-9","article-title":"Prostaglandins in muscle regeneration","volume":"29","author":"Velica","year":"2008","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ni972","article-title":"Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues","volume":"4","author":"Goodarzi","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10059-009-0053-8","article-title":"Leukotriene B4 regulates proliferation and differentiation of cultured rat myoblasts via the BLT1 pathway","volume":"27","author":"Sun","year":"2009","journal-title":"Molecules and Cells"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00296-009-1125-y","article-title":"Regulation of TNFalpha and IL1beta in rheumatoid arthritis synovial fibroblasts by leukotriene B4","volume":"30","author":"Xu","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood-2005-06-2362","article-title":"The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans","volume":"15","author":"Islam","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0952-3278(03)00073-5","article-title":"BLT1 and BLT2: the leukotriene B(4) receptors","volume":"69","author":"Tager","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1073\/pnas.81.11.3501","article-title":"Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4","volume":"81","author":"Payan","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1096\/fasebj.9.14.7589989","article-title":"Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids","volume":"9","author":"Leppert","year":"1995","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1476-5381.1988.tb11727.x","article-title":"Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid","volume":"95","author":"Bacon","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"17501","DOI":"10.1073\/pnas.0505845102","article-title":"Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia","volume":"102","author":"Back","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/000163502753471970","article-title":"Effect on prostaglandin E2 and leukotriene B4 levels by local administration of glucocorticoid in human masseter muscle myalgia","volume":"60","author":"Hedenberg-Magnusson","year":"2002","journal-title":"Acta Odontol Scand"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB73|cit73","first-page":"395","article-title":"The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis","volume":"22","author":"Studynkova","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-kappaB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physrev.00019.2003","article-title":"Cellular and molecular regulation of muscle regeneration","volume":"84","author":"Charge","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1083\/jcb.200707179","article-title":"IKK\/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis","volume":"180","author":"Bakkar","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","article-title":"NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1","volume":"19","author":"Guttridge","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/MCB.02020-06","article-title":"NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes","volume":"27","author":"Wang","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/01.WNL.0000049913.27181.51","article-title":"Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy","volume":"60","author":"Monici","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2006.12.006","article-title":"Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts","volume":"109","author":"Jung","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00075197-200405000-00005","article-title":"Proinflammatory cytokines and skeletal muscle","volume":"7","author":"Spate","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"E1279","DOI":"10.1152\/ajpendo.00054.2002","article-title":"Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha","volume":"283","author":"Fernandez-Celemin","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.4049\/jimmunol.163.6.3474","article-title":"Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity","volume":"163","author":"Jobin","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/art.20960","article-title":"Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation","volume":"52","author":"di","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar1958","article-title":"Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation","volume":"8","author":"Tas","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mus.20425","article-title":"Systemic administration of L-arginine benefits mdx skeletal muscle function","volume":"32","author":"Barton","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2353\/ajpath.2008.071009","article-title":"L-arginine decreases inflammation and modulates the nuclear factor-kappaB\/matrix metalloproteinase cascade in mdx muscle fibers","volume":"172","author":"Hnia","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11926-001-0038-x","article-title":"Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies","volume":"3","author":"Park","year":"2001","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/art.22996","article-title":"Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis","volume":"57","author":"Dastmalchi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mus.21129","article-title":"Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle","volume":"39","author":"Salomonsson","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB94|cit94","unstructured":"Alexanderson HBJ Alemo Munters L Dastmalchi M Lundberg IE http:\/\/acr.confex.com\/acr\/2009\/webprogram\/Paper16124.html 2009"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2174\/138161210790883453","article-title":"Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications","volume":"16","author":"Ciciliot","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1749-6632.1998.tb09894.x","article-title":"Age-associated changes in the response of skeletal muscle cells to exercise and regeneration","volume":"854","author":"Grounds","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0892-1997(05)80319-4","article-title":"Skeletal muscle regeneration after injury: an overview","volume":"8","author":"Bodine-Fowler","year":"1994","journal-title":"J Voice"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1152\/physiol.00009.2007","article-title":"Activity-dependent signaling pathways controlling muscle diversity and plasticity","volume":"22","author":"Schiaffino","year":"2007","journal-title":"Physiology (Bethesda)"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2796.2009.02158.x","article-title":"Skeletal muscle stem cells in developmental versus regenerative myogenesis","volume":"266","author":"Tajbakhsh","year":"2009","journal-title":"J Intern Med"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"R1173","DOI":"10.1152\/ajpregu.00735.2009","article-title":"Regulatory interactions between muscle and the immune system during muscle regeneration","volume":"298","author":"Tidball","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB101|cit101","first-page":"779","article-title":"Muscle regeneration: cellular and molecular events","volume":"23","author":"Karalaki","year":"2009","journal-title":"In Vivo"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB103|cit103","first-page":"1897","article-title":"Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis","volume":"29","author":"Dion","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1475-097X.2010.00973.x","article-title":"Higher proportion of fast-twitch (type II) muscle fibres in idiopathic inflammatory myopathies - evident in chronic but not in untreated newly diagnosed patients","volume":"31","author":"Loell","year":"2011","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/jappl.1995.78.2.629","article-title":"Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm","volume":"78","author":"Dekhuijzen","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00075197-199901000-00003","article-title":"Counter-regulatory hormones and mechanisms in amino acid metabolism with special reference to the catabolic response in skeletal muscle","volume":"2","author":"Hasselgren","year":"1999","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.00073.2004","article-title":"IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1","volume":"287","author":"Sacheck","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00075197-199905000-00002","article-title":"Glucocorticoids and muscle catabolism","volume":"2","author":"Hasselgren","year":"1999","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCO.0b013e32833a5107","article-title":"Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation","volume":"13","author":"Hasselgren","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0016-5085(99)70068-5","article-title":"Inhibition of cytoplasmic phospholipase A2 expression by glucocorticoids in rat intestinal epithelial cells","volume":"116","author":"Dolan-O\u2019keefe","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/bbrc.1996.0432","article-title":"The concerted regulation of cPLA2, COX2, and lipocortin 1 expression by IL-1beta in A549 cells","volume":"220","author":"Croxtal","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.rehab.2010.03.001","article-title":"Non-steroidal anti-inflammatory drugs for athletes: an update","volume":"53","author":"Ziltener","year":"2010","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/japplphysiol.00157.2007","article-title":"The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans","volume":"103","author":"Mackey","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mus.20102","article-title":"Role of cyclooxygenase-1 and -2 in satellite cell proliferation, differentiation, and fusion","volume":"30","author":"Mendias","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"C1651","DOI":"10.1152\/ajpcell.00518.2005","article-title":"The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms","volume":"290","author":"Bondesen","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/030097400447679","article-title":"The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis","volume":"29","author":"Alexanderson","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/art.22780","article-title":"Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis","volume":"57","author":"Alexanderson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","article-title":"Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training programme","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/rheumatology\/37.12.1338","article-title":"Benefit of 6\u2003months long-term physical training in polymyositis\/dermatomyositis patients","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9993(00)90212-0","article-title":"Aerobic capacity in adult dermatomyositis\/polymyositis patients and healthy controls","volume":"81","author":"Wiesinger","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.22687","article-title":"Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial","volume":"57","author":"Chung","year":"2007","journal-title":"Arthritis Rheum-Arthritis Care Res"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BOR.0b013e328324e700","article-title":"Exercise effects in patients with adult idiopathic inflammatory myopathies","volume":"21","author":"Alexanderson","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1600-0838.2006.00602.x","article-title":"Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity","volume":"17","author":"Fischer","year":"2007","journal-title":"Scand J Med Sci Sports"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an endocrine organ: focus on muscle-derived interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0735-1097(03)00848-9","article-title":"Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure","volume":"42","author":"Gielen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cyto.2009.10.007","article-title":"Exercise training changes IL-10\/TNF-alpha ratio in the skeletal muscle of post-MI rats","volume":"49","author":"Batista","year":"2010","journal-title":"Cytokine"},{"key":"10.1111\/j.1365-2796.2010.02334.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1152\/japplphysiol.00085.2007","article-title":"Exercise, MAPK, and NF-kappaB signaling in skeletal muscle","volume":"103","author":"Kramer","year":"2007","journal-title":"J Appl Physiol"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2010.02334.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2796.2010.02334.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T23:01:37Z","timestamp":1712012497000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2010.02334.x"}},"subtitle":["Review: Muscle weakness in myositis"],"short-title":[],"issued":{"date-parts":[[2011,1,9]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02334.x","relation":{},"ISSN":["0954-6820"],"issn-type":[{"value":"0954-6820","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,9]]}}}